Fei Ye
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Pharmacology top 2%
- Flavonoids in Medical Research
Papers in
- Nephrology 13
- Gout, Hyperuricemia, Uric Acid 7
- Co-authors
- David Y. ZhangDiane H. BoschelliFrank BoschelliJennifer M. GolasKim ArndtJudy LucasJosephine W. WuCheng Luo
- Journals
- Bioorganic & Medicinal Chemistry Letters (8 papers)Journal of Medicinal Chemistry (8 papers)Bioorganic Chemistry (5 papers)Nutrition and Cancer (5 papers)Nature Communications (4 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Fei Ye
158 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 143
- Hematology 544
- Pharmacology 546
- Genetics 288
- Molecular Biology 1.8k
- Toxicology 85
Countries citing papers authored by Fei Ye
This map shows the geographic impact of Fei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Ye more than expected).
Fields of papers citing papers by Fei Ye
This network shows the impact of papers produced by Fei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Ye. The network helps show where Fei Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 50 | |
| 2 | 2024 | 14 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 18 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 0 | |
| 12 | 2021 | 41 | |
| 13 | 2021 | 9 | |
| 14 | 2019 | 38 | |
| 15 | 2019 | 4 | |
| 16 | 2017 | 10 | |
| 17 | 2016 | 45 | |
| 18 | 2016 | 10 | |
| 19 | 2011 | 31 | |
| 20 | 2002 | 83 |
About Fei Ye
Fei Ye is a scholar working on Nephrology, Toxicology, Hematology, Molecular Biology and Developmental Neuroscience, having authored 165 papers that have together received 3.8k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (20 papers), Cancer-related gene regulation (16 papers), RNA modifications and cancer (10 papers), Natural product bioactivities and synthesis (10 papers), Protein Tyrosine Phosphatases (9 papers), Ubiquitin and proteasome pathways (7 papers), Gout, Hyperuricemia, Uric Acid (7 papers) and Flavonoids in Medical Research (7 papers). The work is most often cited by research in Hematology (544 citations), Pharmacology (546 citations), Genetics (288 citations), Molecular Biology (1.8k citations) and Toxicology (85 citations). Fei Ye has collaborated with scholars based in China, United States and Germany. Frequent co-authors include David Y. Zhang, Diane H. Boschelli, Frank Boschelli, Jennifer M. Golas, Kim Arndt, Judy Lucas, Josephine W. Wu, Cheng Luo, Jizu Yi and Jia Jin. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Bioorganic Chemistry, Nutrition and Cancer and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.